Luma Mahairi: AI and Digital Hematology Are Transforming Emergency Laboratory Care in 2026
Luma Mahairi, Clinical Research Coordinator III at DM Clinical Research, shared on LinkedIn about a recent article by Ganna Shestakova et al, published in International Journal of Laboratory Hematology, adding:
”One of the most important changes coming to hematology practice in 2026 is the way laboratories will manage hematologic emergencies faster, earlier, and more proactively through automation, digital hematology, and AI-supported workflows.
We are moving away from a purely reactive model of lab medicine toward real-time risk detection and integrated clinical decision support.
Key changes already emerging include:
- AI-assisted peripheral smear review and blast detection
- Earlier identification of acute leukemia, DIC, sepsis-associated coagulopathies, and thrombotic emergencies
- Automated flagging systems for critical CBC/coagulation abnormalities
- Digital hematopathology platforms that improve turnaround time and diagnostic consistency
- Smarter triaging of STAT specimens and emergency hematology workflows
- Integration of molecular, coagulation, and morphology data into unified laboratory dashboards
- Reduced manual review burden through intelligent automation and image analysis
This is especially important in hematology emergencies, where minutes matter.
Faster recognition of blasts, hemolysis, thrombocytopenia, coagulopathies, hyperleukocytosis, or transfusion-related complications can significantly improve patient outcomes.
The hematology laboratory of 2026 is becoming less of a passive testing center and more of an active clinical intelligence hub supporting emergency decision-making in real time.”
Title: Common Hematologic Emergencies – Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias – A Pivotal Role of Clinical Laboratory
Authors: Ganna Shestakova, Nicolas Ulrich Edgar, Anton V. Rets
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke